Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Short-term Investments (2022 - 2025)

Biofrontera (BFRI) has 4 years of Short-term Investments data on record, last reported at $10000.0 in Q3 2025.

  • For Q3 2025, Short-term Investments rose 25.0% year-over-year to $10000.0; the TTM value through Sep 2025 reached $10000.0, up 25.0%, while the annual FY2024 figure was $7000.0, 91.03% down from the prior year.
  • Short-term Investments reached $10000.0 in Q3 2025 per BFRI's latest filing, up from $9000.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $10.5 million in Q4 2022 and bottomed at $7000.0 in Q4 2024.
  • Average Short-term Investments over 4 years is $2.0 million, with a median of $10000.0 recorded in 2024.
  • Peak YoY movement for Short-term Investments: tumbled 99.76% in 2024, then rose 25.0% in 2025.
  • A 4-year view of Short-term Investments shows it stood at $10.5 million in 2022, then tumbled by 99.26% to $78000.0 in 2023, then plummeted by 91.03% to $7000.0 in 2024, then surged by 42.86% to $10000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Short-term Investments were $10000.0 in Q3 2025, $9000.0 in Q2 2025, and $7000.0 in Q1 2025.